Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature
Lucia Novelli, Francesca Motta, Maria De Santis, et al.
Journal of Autoimmunity (2020) Vol. 117, pp. 102592-102592
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

COVID-19 vaccines: where we stand and challenges ahead
Guido Forni, Alberto Mantovani
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 626-639
Open Access | Times Cited: 774
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
Gerd Wallukat, Bettina Hohberger, Katrin Wenzel, et al.
Journal of Translational Autoimmunity (2021) Vol. 4, pp. 100100-100100
Open Access | Times Cited: 293
Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
Renin Chang, Thomas Yen‐Ting Chen, Shiow‐Ing Wang, et al.
EClinicalMedicine (2023) Vol. 56, pp. 101783-101783
Open Access | Times Cited: 196
COVID-19 and the clinical course of rheumatic manifestations
Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
Clinical Rheumatology (2021) Vol. 40, Iss. 7, pp. 2611-2619
Open Access | Times Cited: 116
The intersection of COVID-19 and autoimmunity
Jason S. Knight, Roberto Caricchio, Jean‐Laurent Casanova, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 111
The Role of Viral Infections in the Onset of Autoimmune Diseases
Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 782-782
Open Access | Times Cited: 74
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 72
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
Michele Ghielmetti, Helen Dorothea Schaufelberger, Giorgina Mieli‐Vergani, et al.
Journal of Autoimmunity (2021) Vol. 123, pp. 102706-102706
Open Access | Times Cited: 95
Vaccinations and Autoimmune Diseases
Bianca Olivieri, Corrado Betterle, Giovanna Zanoni
Vaccines (2021) Vol. 9, Iss. 8, pp. 815-815
Open Access | Times Cited: 76
Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care
Umer Syed, Anuradhaa Subramanian, David C. Wraith, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Long COVID in autoimmune rheumatic diseases
Yuliya Fedorchenko, Olena Zimba
Rheumatology International (2023) Vol. 43, Iss. 7, pp. 1197-1207
Open Access | Times Cited: 24
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients
Y. Lavi, Aristo Vojdani, Gilad Halpert, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 687-687
Open Access | Times Cited: 21
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
Giuseppe Novelli, Michela Biancolella, Ruty Mehrian‐Shai, et al.
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 53
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis (2021) Vol. 48, Iss. 01, pp. 072-092
Open Access | Times Cited: 52
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов, А. М. Лила, Mazurov Vi, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 3, pp. 239-254
Open Access | Times Cited: 50
Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19
Frits A.J. Muskiet, Pedro Carrera‐Bastos, Leo Pruimboom, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1388-1388
Open Access | Times Cited: 29
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
Emanuele Nappi, Maria De Santis, Giovanni Paoletti, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 716-716
Open Access | Times Cited: 29
COVID-19 and the antiphospholipid syndrome
Manuel Serrano, Gerard Espinosa, Antonio Serrano, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 12, pp. 103206-103206
Open Access | Times Cited: 27
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome
Rodrigo Aguirre del-Pino, Rory C. Monahan, T. Huizinga, et al.
Seminars in Thrombosis and Hemostasis (2024) Vol. 50, Iss. 06, pp. 817-828
Open Access | Times Cited: 5
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Pediatric Autoimmune Diseases in the Light of COVID-19 Pandemic, A Retrospective Observational Big Data Study.
Rim Kasem Ali Sliman, Hilla Cohen, Shereen Shehadeh, et al.
Journal of Translational Autoimmunity (2025), pp. 100281-100281
Open Access
Molecular Mimicry Impact of the COVID-19 Pandemic: Sequence Homology Between SARS-CoV-2 and Autoimmune Diseases Epitopes
Pablo Maldonado-Catala, Ramkiran Gouripeddi, Naomi Schlesinger, et al.
ImmunoInformatics (2025), pp. 100050-100050
Open Access
Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
Sara Taha, Sara Samaan, Rehab Ali Ibrahim, et al.
European Cytokine Network (2021) Vol. 32, Iss. 4, pp. 83-88
Open Access | Times Cited: 38
Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement
Mugdha Mohkhedkar, Siva Sai Krishna Venigalla, Janakiraman Vani
Molecular Immunology (2021) Vol. 137, pp. 105-113
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top